Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Lanreotide: Applications, Medical uses & Side effects

Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Lanreotide topic overview

The analysis highlights Applications, Medical uses and Side effects as prominent areas in the source structure around Lanreotide.

Related topics
31
Source areas
5
Connected nodes
36
Extracted relationships
44
Concept neighborhoods
15
Bridge connections
36

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 10 topics
Medical uses · 7 topics
Pharmacology · 6 topics
Side effects · 6 topics
Formulations · 2 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol)
Interactive image
AHFS/Drugs.com
Monograph
ATC code
H01CB03 (WHO)
Bioavailability
Approximately 80%
CAS Number
108736-35-2 N
ChEMBL
ChEMBL1201185 N

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Side effects

Pharmacology

Formulations

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Lanreotide connects Entity context

The extracted context around Lanreotide shows recurring relationship patterns in the source. For example, Lanreotide → Canada, In, TSH, United Kingdom, United States, VIPomas Another extracted example is Lanreotide → Somatuline Autogel, Somatuline Depot, Somatuline LA, UK, US. Use these groups to spot repeated connection types before inspecting the individual relationships.

Lanreotide

Top relations

related to Medical uses · 6
Lanreotide → Canada, In, TSH, United Kingdom, United States, VIPomas
related to Formulations · 5
Lanreotide → Somatuline Autogel, Somatuline Depot, Somatuline LA, UK, US
Legal status · 3
Lanreotide → AU: S4 (Prescription only), UK: POM (Prescription only), US: ℞-only
License data · 2
Lanreotide → US DailyMed: Lanreotide, US FDA: Lanreotide
has effect · 2
Lanreotide → Isolated, The
related to Pharmacology · 2
Lanreotide → However, TSH
3D model (JSmol) · 1
Lanreotide → Interactive image
AHFS/Drugs.com · 1
Lanreotide → Monograph
ATC code · 1
Lanreotide → H01CB03 (WHO)
Bioavailability · 1
Lanreotide → Approximately 80%

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

somatostatin treatment used tumors acromegaly fda name neuroendocrine several united acetate medical effects us release somatuline administration 30 analogue also

Lanreotide relationships Subject–Predicate–Object triples

TTTA extracted 44 structured relationships around Lanreotide. Examples in this analysis include Lanreotide → 3D model (JSmol) → Interactive image and Lanreotide → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Lanreotide3D model (JSmol)Interactive image1.00infobox
LanreotideAHFS/Drugs.comMonograph1.00infobox
LanreotideATC codeH01CB03 (WHO)1.00infobox
LanreotideBioavailabilityApproximately 80%1.00infobox
LanreotideCAS Number108736-35-2 N1.00infobox
LanreotideChEMBLChEMBL1201185 N1.00infobox
LanreotideChemSpider64450 Y1.00infobox
LanreotideCompTox Dashboard (EPA)DTXSID608975141.00infobox
LanreotideDrugBankDB067911.00infobox
LanreotideECHA InfoCard100.215.9921.00infobox
LanreotideElimination half-life2 hours (immediate release) 5 days (sustained release)1.00infobox
LanreotideExcretionMostly bile duct1.00infobox
LanreotideFormulaC54H69N11O10S21.00infobox
LanreotideIUPHAR/BPS20311.00infobox
LanreotideKEGGD046661.00infobox
LanreotideLegal statusAU: S4 (Prescription only)1.00infobox
LanreotideLegal statusUK: POM (Prescription only)1.00infobox
LanreotideLegal statusUS: ℞-only1.00infobox
LanreotideLicense dataUS DailyMed: Lanreotide1.00infobox
LanreotideLicense dataUS FDA: Lanreotide1.00infobox
LanreotideMetabolismIn GI tract1.00infobox
LanreotideMolar mass1096.33 g·mol−11.00infobox
LanreotideOther namesLanreotide acetate (JAN JP), Lanreotide acetate (USAN US)1.00infobox
LanreotidePregnancy categoryAU: C1.00infobox
LanreotideProtein binding78%1.00infobox
LanreotidePubChem CID713491.00infobox
LanreotideRoutes of administrationIntramuscular, subcutaneous1.00infobox
LanreotideTrade namesSomatuline1.00infobox
LanreotideUNII0G3DE8943Y1.00infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Lanreotide bring nearby vocabulary together. In this analysis, examples include Tumors, Used and Somatostatin. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Lanreotide
    • Tumors
    • Used
    • Somatostatin
    • Treatment
    • Acromegaly
    • Citation
    • Effects
    • Medical
    • Name
    • Needed
    • Neuroendocrine
    • Release
  • lanreotide
    • Tumors
    • Used
    • Somatostatin
    • Treatment
    • Acromegaly
    • Citation
    • Effects
    • Medical
    • Name
    • Needed
    • Neuroendocrine
    • Release
  • acromegaly
    • Carcinoid
    • Caused
    • Management
    • Somatuline
    • Symptoms
    • Name
    • Neuroendocrine
    • Tumors
    • Used
    • Treatment
    • Acetate
    • Administration
  • carcinoid syndrome
    • Caused
    • Management
    • Somatuline
    • Symptoms
    • Name
    • Neuroendocrine
    • Tumors
    • Used
    • Acetate
    • Administration
    • Formulations
    • Half-life
  • acetate
    • Administration
    • Carcinoid
    • Caused
    • Formulations
    • Half-life
    • Management
    • Pituitary
    • Side
    • Somatuline
    • Symptoms
    • Trade
    • Uk
  • food and drug administration
    • Fda
    • Approved
    • Available
    • Canada
    • Carcinoid
    • Caused
    • Formulations
    • Half-life
    • Including
    • Kingdom
    • Management
    • Pituitary
  • carcinoid tumors
    • Caused
    • Management
    • Somatuline
    • Symptoms
    • Name
    • Neuroendocrine
    • Tumors
    • Used
    • Fda
    • Us
    • Acetate
    • Administration
  • side effects
    • Medical
    • Formulations
    • Half-life
    • Side
    • Trade
    • Uk
    • Citation
    • Name
    • Needed
    • Release
    • Us
    • Used

Connections between topic areas Semantic bridges

For Lanreotide, one of the stronger structural bridges in this analysis connects Lanreotide with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Lanreotide — Overview · splits 26 ⟂ 11
Lanreotide — Medical uses · splits 29 ⟂ 8
Lanreotide — Side effects · splits 30 ⟂ 7
Lanreotide — Pharmacology · splits 30 ⟂ 7
Lanreotide — Formulations · splits 34 ⟂ 3

Map overview Semantic statistics

Lanreotide

Nodes37
Edges36
Triples44
Avg. degree1.95
Density0.054054
Components1

Source & methodology

TTTA analyzes the structure around Lanreotide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Medical uses & Side effects, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Lanreotide · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.